Gelion PLC GELN
LSE · United Kingdom · Producer Manufacturing
GBp 12.90-0.10 (-0.77%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Cordiant Digital Infrastructure Ltd (LSE:CORD, FRA:86L) says booming AI demand is starting to convert into real contracted revenue. Quarterly revenue jumped over 20%, with a pipeline worth potentially over £1 billion. Digitalbox PLC (AIM:DBOX, FRA:RLXB) is pushing into original video with a growing creator network. It's aiming to hit around 500 videos a month by October as it responds to a turbulent first half. Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF, FRA:VD5N) says second-quarter production from its non- operated US portfolio beat forecasts, up around 45% year on year. Its lender's also reaf
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) told investors it has secured six patents covering key elements of its lithium-sulfur battery technology as it pushes ahead with commercialisation and a planned expansion into the US market. The patents comprise three grants in the United States, two...
Chesnara PLC (LSE:CSN) saw operating capital generation jump 79% to £96 million in the first half. CEO Steve Murray also highlighted the group's 185% solvency coverage ratio and an active acquisition pipeline. Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) has raised £1.3 million to push forward its CNS drug pipeline. That includes trials for alcohol use disorder and addiction treatments. hVIVO PLC (AIM:HVO) has bought CRS Berlin to expand into dermatology and women's health trials. The CEO says it opens up new markets and cross-selling opportunities in Germany. Gelion PLC (AIM:GELN, OTC:G
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.